Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring
Confounding introduced by individuals’ sexual risk behavior is potentially a significant source of bias in HIV-1 prevention intervention studies. To more completely account for sexual behaviors when assessing the efficacy of the monthly dapivirine ring, a new longer-acting HIV-1 prevention option for women, we estimated per-sex-act risk reduction associated with product use.
December 2023
Click for full info +Full Info:
Resource Type:
Database
Journal Article
Journal Article
Resource
Citation:
Confounding introduced by individuals’ sexual risk behavior is potentially a significant source of bias in HIV-1 prevention intervention studies. To more completely account for sexual behaviors when assessing the efficacy of the monthly dapivirine ring, a new longer-acting HIV-1 prevention option for women, we estimated per-sex-act risk reduction associated with product use.
Authors: Stalter, R.M., Dong, T.Q., Hendrix, C.W., Palanee-Phillips, T., van der Straten, A., Hillier, S.L., Kiweewa, F.M., Mgodi, N.M., Marzinke, M.A., Bekker, L.G. and Soto-Torres, L.
Health Risks(s):
- HIV
Product type(s):
- HIVinhibitor
- IVR
Topic(s):
- Policy
- Trials
- Social
Region(s)
- Africa